Literature DB >> 29753735

Molecular characterization of single-chain antibody variable fragments (scFv) specific to Pep27 from Streptococcus pneumoniae.

Dongho Kim1, ShinA Jang1, Jihye Oh1, Seungsu Han1, Soobin Park1, Prachetash Ghosh2, Dong-Kwon Rhee2, Sangho Lee3.   

Abstract

Pep27 from Streptococcus pneumoniae is reported to initiate pneumococcal autolysis, thereby constituting a major virulence factor. Although a few antisera recognizing Pep27 have been reported, no monoclonal, well-characterized antibody for Pep27 has been developed. Here we screened two single-chain antibody variable fragments (scFv) using a phage display from a large human synthetic scFv library to select clones E2 and F9. Dissociation constants (Kd) of E2 and F9 were 1.1 μM and 0.50 μM, respectively. E2 and F9 did not cross-react with other pneumococcal and unrelated proteins. The epitopes of Pep27 were localized to residues 24, 26 and 27 by alanine scanning. Molecular docking analysis supported the experimentally investigated epitope. The E2 and F9 clones specifically detected Pep27 in an environment mimicking in vivo conditions, demonstrated in human serum. The scFv clones characterized here represent molecular tools for the detection of pneumococcal diseases with potential for further improvement in affinity.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Affinity; Epitope; Pep27; Streptococcus pneumoniae; scFv

Mesh:

Substances:

Year:  2018        PMID: 29753735     DOI: 10.1016/j.bbrc.2018.05.054

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Monoclonal antibody-based therapies for bacterial infections.

Authors:  Michael P Motley; Kasturi Banerjee; Bettina C Fries
Journal:  Curr Opin Infect Dis       Date:  2019-06       Impact factor: 4.915

Review 2.  Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.

Authors:  Kristian Daniel Ralph Roth; Esther Veronika Wenzel; Maximilian Ruschig; Stephan Steinke; Nora Langreder; Philip Alexander Heine; Kai-Thomas Schneider; Rico Ballmann; Viola Fühner; Philipp Kuhn; Thomas Schirrmann; André Frenzel; Stefan Dübel; Maren Schubert; Gustavo Marçal Schmidt Garcia Moreira; Federico Bertoglio; Giulio Russo; Michael Hust
Journal:  Front Cell Infect Microbiol       Date:  2021-07-07       Impact factor: 5.293

3.  Blocking of the IL-33/ST2 Signaling Axis by a Single-Chain Antibody Variable Fragment (scFv) Specific to IL-33 with a Defined Epitope.

Authors:  Soo Bin Park; Sun-Jick Kim; Sang Woo Cho; Cheol Yong Choi; Sangho Lee
Journal:  Int J Mol Sci       Date:  2020-09-22       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.